Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myelomaTakashi Yoshida(Nagoya City University), Shinsuke Iida(Nagoya City University)PLoS ONEMay 8, 201810.1371/journal.pone.0196780Cited by 28SaveCiteExport RISWatch citationsRelated PapersIdentification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing|Blood Cancer Journal|2012|181Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy|Blood Cancer Journal|2015|49